Влияние абортов на здоровье женщины

1. Bearak J., Popinchalk A., Ganatra B., Moller A.-B., Tunçalp Ö., Beavin C. et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Glob. Heal. 2020; 8(9): e1152-61. https://dx.doi.org/10.1016/S2214-109X(20)30315-6
2. Bridwell R.E., Long B., Montrief T., Gottlieb M. Post-abortion complications: a narrative review for emergency clinicians. West. J. Emerg. Med. 2022; 23(6): 919-25. https://dx.doi.org/10.5811/westjem.2022.8.57929
3. Kerns J.L., Brown K., Nippita S., Steinauer J. Society of Family Planning Clinical Recommendation: Management of hemorrhage at the time of abortion. Contraception. 2024; 129: 110292. https://dx.doi.org/10.1016/j.contraception.2023.110292
4. Choudhary N., Saha S.C., Gopalan S. Abortion procedures in a tertiary care institution in India. Int. J. Gynaecol. Obstet. 2005; 91(1): 81-6. https://dx.doi.org/10.1016/j.ijgo.2005.06.012
5. Frick A.C., Drey E.A., Diedrich J.T., Steinauer J.E. Effect of prior cesarean delivery on risk of second-trimester surgical abortion complications. Obstet. Gynecol. 2010; 115(4): 760-4. https://dx.doi.org/10.1097/AOG.0b013e3181d43f42
6. ACOG Practice Bulletin No. 135: Second-Trimester Abortion. Obstet. Gynecol. 2013; 121(6): 1394-1406. https://dx.doi.org/10.1097/01.AOG.0000431056.79334.cc
7. Ashok P.W., Templeton A., Wagaarachchi P.T., Flett G.M.M. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2004; 69(1): 51-8. https://dx.doi.org/10.1016/j.contraception.2003.09.006
8. Goyal V. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review. Obstet. Gynecol. 2009; 113(5): 1117-23. https://dx.doi.org/10.1097/AOG.0b013e31819dbfe2
9. White K., Carroll E., Grossman D. Complications from first-trimester aspiration abortion: a systematic review of the literature. Contraception. 2015; 92(5): 422-38. https://dx.doi.org/10.1016/j.contraception.2015.07.013
10. Premkumar A., Huysman B., Cheng C., Einerson B.D., Moayedi G. Placenta accreta spectrum in the second trimester: a clinical conundrum in procedural abortion care. Am. J. Obstet. Gynecol. 2025; 232(1): 92-101. https://dx.doi.org/10.1016/j.ajog.2024.07.045
11. Benson M.D. Amniotic fluid embolism mortality rate. J. Obstet. Gynaecol. Res. 2017; 43(11): 1714-8. https://dx.doi.org/10.1111/jog.13445
12. Creanga A.A., Syverson C., Seed K., Callaghan W.M. Pregnancy-related mortality in the United States, 2011–2013. Obstet. Gynecol. 2017; 130(2): 366-73. https://dx.doi.org/10.1097/AOG.0000000000002114
13. Niinimäki M., Pouta A., Bloigu A., Gissler M., Hemminki E., Suhonen S., Heikinheimo O. Immediate complications after medical compared with surgical termination of pregnancy. Obstet. Gynecol. 2009; 114(4): 795-804. https://dx.doi.org/10.1097/AOG.0b013e3181b5ccf9
14. World Health Organization. Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. 6th ed. 2011. 57 p.
15. Patel A., Talmont E., Morfesis J., Pelta M., Gatter M., Momtaz M.R. et al. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception. 2006; 73(4): 420-30. https://dx.doi.org/10.1016/j.contraception.2005.10.004
16. Parazzini F., Mais V., Cipriani S., Busacca M., Venturini P. Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009; 143(2): 103-6. https://dx.doi.org/10.1016/j.ejogrb.2008.12.010
17. Pun S. Induced abortion: a risk factor for adenomyosis. J. Nepal Health Res. Counc. 2023; 20(4): 913-5. https://dx.doi.org/10.33314/jnhrc.v20i4.4649
18. Shrestha A. Risk factors for adenomyosis. J. Nepal Health Res. Counc. 2012; 10(22): 229-33.
19. Genc M., Genc B., Cengiz H. Adenomyosis and accompanying gynecological pathologies. Arch. Gynecol. Obstet. 2015; 291(4): 877-81. https://dx.doi.org/10.1007/s00404-014-3498-8
20. Kobayashi H., Matsubara S., Imanaka S. Clinicopathological features of different subtypes in adenomyosis: focus on early lesions. PLOS One. 2021; 16(7): e0254147. https://dx.doi.org/10.1371/journal.pone.0254147
21. Grimes D.A., Benson J., Singh S., Romero M., Ganatra B., Okonofua F.E., Shah I.H. Unsafe abortion: the preventable pandemic. Lancet. 2006; 368(9550): 1908-19. https://dx.doi.org/10.1016/S0140-6736(06)69481-6
22. Чучалина Л.Ю. Роль искусственного прерывания беременности в первом триместре в формировании вторичного бесплодия. Акушерство и гинекология. 2016; 11: 113-6.
23. Wang H., Guo X., Song Q., Su W., Meng M., Sun C. et al. Association between the history of abortion and gestational diabetes mellitus: a meta-analysis. Endocrine. 2023; 80(1): 29-39. https://dx.doi.org/10.1007/s12020-022-03246-x
24. Zhang J., Savitz D.A. Maternal age and placenta previa: a population-based, case-control study. Am. J. Obstet. Gynecol. 1993; 168(2): 641-5. https://dx.doi.org/10.1016/0002-9378(93)90511-G
25. Faiz A.S., Ananth C.V. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J. Matern. Fetal Neonatal. Med. 2003; 13(3): 175-90. https://dx.doi.org/10.1080/jmf.13.3.175.190
26. Hung T.H., Hsieh C.C., Hsu J.J., Chiu T.H., Lo L.M., Hsieh T.T. Risk factors for placenta previa in an Asian population. Int. J. Gynaecol. Obstet 2007; 97(1): 26-30. https://dx.doi.org/10.1016/j.ijgo.2006.12.006
27. Johnson L.G., Mueller B.A., Daling J.R. The relationship of placenta previa and history of induced abortion. Int. J. Gynaecol. Obstet. 2003; 81(2): 191-8. https://dx.doi.org/10.1016/s0020-7292(03)00004-3
28. Zhu Q.X., Gao E.S., Chen A.M., Luo L., Cheng Y.M., Yuan W. Mifepristone-induced abortion and placental complications in subsequent pregnancy. Hum. Reprod. 2009; 24(2): 315-9. https://dx.doi.org/10.1093/humrep/den426
29. Koifman A., Levy A., Zaulan Y., Harlev A., Mazor M., Wiznitzer A., Sheiner E. The clinical significance of bleeding during the second trimester of pregnancy. Arch. Gynecol. Obstet. 2008; 278(1): 47-51. https://dx.doi.org/10.1007/s00404-007-0530-2
30. Lowit A., Bhattacharya S., Bhattacharya S. Obstetric performance following an induced abortion. Best. Pract. Res. Clin. Obstet. Gynaecol. 2010; 24(5): 667-82. https://dx.doi.org/10.1016/j.bpobgyn.2010.02.015
31. Shah P.S., Zao J. Induced termination of pregnancy and low birthweight and preterm birth: a systematic review and meta-analyses. BJOG. 2009; 116(11): 1425-42. https://dx.doi.org/10.1111/j.1471-0528.2009.02278.x
32. Saccone G., Perriera L., Berghella V. Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2016; 214(5): 572-91. https://dx.doi.org/10.1016/j.ajog.2015.12.044
33. Lemmers M., Verschoor M.A.C., Hooker A.B., Opmeer B.C., Limpens J., Huirne J.A.F. et al. Dilatation and curettage increases the risk of subsequent preterm birth: a systematic review and meta-analysis. Hum. Reprod. 2016; 31(1): 34-45. https://dx.doi.org/10.1093/humrep/dev274
34. Freak-Poli R., Chan A., Tucker G., Street J. Previous abortion and risk of pre-term birth: a population study. J. Matern. Fetal Neonatal Med. 2009; 22(1): 1-7. https://dx.doi.org/10.1080/14767050802531813
35. Mitrogiannis I., Evangelou E., Efthymiou A., Kanavos T., Birbas E., Makrydimas G. et al. Risk factors for preterm birth: an umbrella review of meta-analyses of observational studies. BMC Med. 2023; 21(1): 494. https://dx.doi.org/10.1186/s12916-023-03171-4
36. Brittain J.J., Wahl S.E., Strauss J.F., Romero R., Wolf H.M., Murphy K. et al. Prior spontaneous or induced abortion is a risk factor for cervical dysfunction in pregnant women: a systematic review and meta-analysis. Reprod. Sci. 2023; 30(7): 2025-39. https://dx.doi.org/10.1007/s43032-023-01170-7
37. Kyriacou H., Al-Mohammad A., Muehlschlegel C., Foster-Davies L., Bruco M.E.F., Legard C. et al. The risk of cardiovascular diseases after miscarriage, stillbirth, and induced abortion: a systematic review and meta-analysis. Eur. Hear. J. Open. 2022; 2(5): oeac065. https://dx.doi.org/10.1093/ehjopen/oeac065
38. Brind J., Chinchilli V.M., Severs W.B., Summy-Long J. Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis. J. Epidemiol. Community Health. 1996; 50(5): 481-96. https://dx.doi.org/10.1136/jech.50.5.481
39. Islam M.A., Sathi N.J., Abdullah H.M., Tabassum T.A. Meta-analysis of induced abortion, alcohol consumption, and smoking triggering breast cancer risk among women from developed and least developed countries. Int. J. Clin. Pract. 2022; 2022: 6700688. https://dx.doi.org/10.1155/2022/6700688
40. Brind J., Condly S.J., Lanfranchi A., Rooney B. Induced abortion as an independent risk factor for breast cancer: a systematic review and meta-analysis of studies on south asian women. Issues Law Med. 2018; 33(1): 32-54.
41. Cuenca D. Pregnancy loss: Consequences for mental health. Front. Glob. Womens Health. 2022; 3: 1032212. https://dx.doi.org/10.3389/fgwh.2022.1032212
42. Mergl R., Quaatz S.M., Edeler L.M., Allgaier A.K. Grief in women with previous miscarriage or stillbirth: a systematic review of cross-sectional and longitudinal prospective studies. Eur. J. Psychotraumatol. 2022; 13(2): 2108578. https://dx.doi.org/10.1080/20008066.2022.2108578
43. Bellieni C.V., Buonocore G. Abortion and subsequent mental health: Review of the literature. Psychiatry Clin. Neurosci. 2013; 67(5): 301-10. https://dx.doi.org/10.1111/pcn.12067
44. Coleman P.K. Abortion and mental health: quantitative synthesis and analysis of research published 1995–2009. Br. J. Psychiatry. 2011; 199(3): 180-6. https://dx.doi.org/10.1192/bjp.bp.110.077230
45. Charles V.E., Polis C.B., Sridhara S.K., Blum R.W. Abortion and long-term mental health outcomes: a systematic review of the evidence. Contraception. 2008; 78(6): 436-50. https://dx.doi.org/10.1016/j.contraception.2008.07.005
46. Gissler M., Karalis E., Ulander V.M. Decreased suicide rate after induced abortion, after the Current Care Guidelines in Finland 1987–2012. Scand. J. Public Health. 2015; 43(1): 99-101. https://dx.doi.org/10.1177/1403494814560844

Поступила 14.05.2025

Принята в печать 23.06.2025